
Christy Santhosh
Articles
-
2 weeks ago |
today.westlaw.com | Sneha K |Christy Santhosh |Shounak Dasgupta
(Reuters) -Walgreens, which is in the process of being taken private by Sycamore Partners, beat Wall Street estimates for quarterly profit as the pharmacy chain operator benefited from a turnaround effort that included closing underperforming stores....
-
4 weeks ago |
today.westlaw.com | Shailesh Kuber |Christy Santhosh
(Reuters) -Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, the cause of which could not immediately be known. The company said it is recalling these lenses, which are part of...
-
1 month ago |
streetinsider.com | Bhanvi Satija |Christy Santhosh
By Bhanvi Satija and Christy Santhosh (Reuters) -Illumina said on Tuesday that activist investor Keith Meister will join the gene-sequencing maker's board and former U.S. Food and Drug Administration Commissioner Scott Gottlieb would take over as the company's chairman later this week. Illumina has been caught in the middle of a tariff war between the U.S. and China that has compelled it to cut its annual forecast and implement a cost-savings plan.
-
1 month ago |
today.westlaw.com | Bhanvi Satija |Shilpi Majumdar |Christy Santhosh |Shounak Dasgupta
(Reuters) - Illumina said on Tuesday activist investor Keith Meister would join the gene-sequencing maker's board and former U.S. Food and Drug Administration Commissioner Scott Gottlieb would take over as the company's chairman later this week....
-
1 month ago |
health.economictimes.indiatimes.com | Bhanvi Satija |Christy Santhosh
Bengaluru: Measles cases in Texas and New Mexico rose to 317 on Tuesday from 294 four days ago, as the U.S. battles one of the largest measles outbreaks in the past decade. The country has already surpassed last year's count of 285 infections, according to data from the U.S. Centers for Disease Control and Prevention.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →